| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 129646 |
s-四嗪二胺(Tz)的化学结构 |
542 |
wyh |
2024-08-15 |
| 129647 |
s-四嗪的共价有机框架材料(TZA-COF) |
295 |
wyh |
2024-08-15 |
| 129648 |
3,6-二叠氮基-1,2,4,5-四嗪(DAT)的反应活性与性质 |
397 |
wyh |
2024-08-15 |
| 129649 |
二噻吩基-s-四嗪（TTz）；dithienyl-s-tetrazine (TTz) |
278 |
wyh |
2024-08-15 |
| 129650 |
二肼基四嗪盐(DNOBT-DHT)的二肼基四嗪盐 |
308 |
wyh |
2024-08-15 |
| 129651 |
四嗪基UIO-66；HP-UIO-66dhtz；HP-UIO-66dhtz-7 |
285 |
wyh |
2024-08-15 |
| 129652 |
1,2,3-三唑-[4,5-e]-1,2,3,4-四嗪阴离子([TT]-) |
295 |
wyh |
2024-08-15 |
| 129653 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪(4-bptz) |
304 |
wyh |
2024-08-15 |
| 129654 |
金纳米颗粒表面修饰四嗪五聚乙二醇活泼酯；AbTCO |
248 |
wyh |
2024-08-15 |
| 129655 |
3-(3,5-二甲基吡唑基)-6-苯基亚甲基腙-1,2,4,5-四嗪(DAHBTz) |
221 |
wyh |
2024-08-15 |
| 129656 |
3-氨基-1,2,4-三唑的理化性质 |
574 |
wyh |
2024-08-15 |
| 129657 |
3,6-双胍基 -1,2,4,5-四嗪(DGTZ)的结构特点 |
275 |
wyh |
2024-08-15 |
| 129658 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
216 |
wyh |
2024-08-15 |
| 129659 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2)；3,6odiamino-1,2,4,5-tetrazine-l,4-dioxide |
242 |
wyh |
2024-08-15 |
| 129660 |
5-TAMRA-Tz；S-四嗪近红外花菁染料；5-TAMRA-tetrazine |
219 |
wyh |
2024-08-15 |
| 129661 |
3,6-二烷基-1,2,4,5-四嗪（或-s-四嗪）；3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
261 |
wyh |
2024-08-15 |
| 129662 |
6-（乙酰氨基）-3-（甲硫基）-1,2,4-四嗪；6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
284 |
wyh |
2024-08-15 |
| 129663 |
3，6-d氨基-1，2，4，5-四嗪；3,6-d iam ino-1,2,4,5-tet-razine(DATZ) |
213 |
wyh |
2024-08-15 |
| 129664 |
3，6-二(吡啶-2-基)-1，4-二氢-1，2，4，5-四嗪 |
334 |
wyh |
2024-08-15 |
| 129665 |
(NH2TzDMP)3Ni][NO3]2；3-氨基-6-(3，5-二甲基吡唑)四嗪配合物 |
207 |
wyh |
2024-08-15 |
| 129666 |
(64)Cu-Tz-SarAr；64铜-四嗪-SarAr；(64)Cu-Tetrazine-SarAr |
291 |
wyh |
2024-08-15 |
| 129667 |
DOTA-PEG11-Tz；DOTA-十一聚乙二醇-四嗪；DOTA-PEG11-Tetrazine |
232 |
wyh |
2024-08-15 |
| 129668 |
12Pb-DOTA-Tz；12Pb-大环化合物-四嗪 |
197 |
wyh |
2024-08-15 |
| 129669 |
DOTA-TZ-Bis-cyclo(RGDfK)；DOTA-四嗪-Bis-环肽 |
190 |
wyh |
2024-08-15 |
| 129670 |
DH-G4-DBCO 生物正交树状大分子4.0代(G4)树状大分子水凝胶 |
257 |
zyl |
2024-08-15 |
| 129671 |
DBCO功能化的紫杉醇负载聚丙交酯乙交酯共聚物PLGA纳米颗粒 (DBCO-PTX NP) |
231 |
zyl |
2024-08-15 |
| 129672 |
四嗪修饰蛋白分解靶向嵌合体；Tetrazine--PROTACs |
242 |
wyh |
2024-08-15 |
| 129673 |
H2NO-DOTA-Eu 1,4,7,10-四氮杂环十二烷金属离子螯合剂 |
207 |
zyl |
2024-08-15 |
| 129674 |
azido-TM456 叠氮修饰的调节蛋白456 |
229 |
zyl |
2024-08-15 |
| 129675 |
[99mtc]hyNIC-peg 11-Tz；99mtc标记6-肼基烟酸修饰的四嗪；[99mtc]hyNIC-peg 11--Tetrazine |
255 |
wyh |
2024-08-15 |
| 129676 |
Amine-PEGn-CHOL 氨基-PEG-胆固醇 |
200 |
zyl |
2024-08-15 |
| 129677 |
MTzL/BCNL；甲基四嗪偶联双环单酮 |
230 |
wyh |
2024-08-15 |
| 129678 |
CHOL–PEG2000–DBCO 胆固醇-PEG二苯并环辛烯 cholesterol-PEG-dibenzocyclooctyne |
218 |
zyl |
2024-08-15 |
| 129679 |
N-乙酰氨基葡萄糖（NAG/GlcNAc） |
1022 |
wyh |
2024-08-15 |
| 129680 |
乙酰化d-甘露糖胺二苯并环辛炔 DBCO-Ac4Man |
239 |
zyl |
2024-08-15 |
| 129681 |
间苯四嗪(mPTet)的结构特征 |
269 |
wyh |
2024-08-15 |
| 129682 |
BOD-TZ-TMR；BODIPY-TZ-TMR；氟化硼二吡咯-四嗪-罗丹明 |
253 |
wyh |
2024-08-15 |
| 129683 |
3-（丁基-3-炔-1-基）-6-苯基-1,2,4,5-四嗪 |
224 |
wyh |
2024-08-15 |
| 129684 |
PLA微球，粒径100nm左右,5mg/ml PLA荧光微球，PCL荧光微球 |
507 |
ssl |
2024-08-15 |
| 129685 |
四嗪功能化钌(Ⅱ)声敏剂Tz-Ru |
269 |
wyh |
2024-08-15 |
| 129686 |
UDP-HTz-NAM；udp-糖修饰四嗪取代的N-乙酰胞壁酸衍生探针 |
320 |
wyh |
2024-08-15 |
| 129687 |
NP-Tz11；NP-Tz13；四嗪纳米粒 |
241 |
wyh |
2024-08-15 |
| 129688 |
双齿吡啶基-四嗪修饰的绿色荧光蛋白；GFP-(pyTz)2 |
295 |
wyh |
2024-08-15 |
| 129689 |
Lips-Tz+TCO-Dox；脂质体-四嗪/反式环辛烯-阿霉素 |
378 |
wyh |
2024-08-15 |
| 129690 |
DBCO-SS-lPEI 二苯并环辛基DBCO-可还原双硫键-聚乙烯亚胺（lPEI）复合物 |
216 |
zyl |
2024-08-15 |
齐岳微信公众号
官方微信
库存查询